Improvements to tiny body-on-a-chip devices could lead to next-generation pre-clinical testing of drug toxicity
Researchers at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) in Japan have designed a small ‘body-on-a-chip’ device that can test the side effects of drugs s on human cells. The device solves some issues with current, similar microfluidic devices and offers promise for the next generation of pre-clinical drug tests.
The Integrated Heart/Cancer on a Chip (iHCC) was used to test the toxicity of the anti-cancer drug doxorubicin on heart cells. The researchers, led by iCeMS’s Ken-ichiro Kamei, found that, while the drug itself was not toxic to heart cells, a metabolite of the drug resulting from its interaction with cancer cells was.
The device is smaller than a microscope glass slide. It contains six tiny chambers; every two are connected by microchannels with a series of port inlets and valves. A pneumatic pump controls movement of fluid through the channels. Every two chambers and their separate microchannel system constitute one test bed. Three test beds in the device allow for the introduction of minor changes in each bed to simultaneously compare results.
The team first tested doxorubicin’s effects on heart cells and liver cancer cells cultured separately in small wells. The drug had the expected anti-cancer effect on the cancer cells without causing damage to the heart cells.
They then ran the test using the iHCC device. Heart cells were placed in one chamber while liver cancer cells were placed in the other. Doxorubicin was introduced into a cell culture medium circulating through a closed-loop system of microchannels that connects the two chambers, mimicking the blood’s circulatory system. In this way, the drug flows unidirectionally in a continuous loop through both chambers.
The team found signs of toxicity in both cancer and heart cells. They hypothesized that a compound, doxorubicinol, which is a metabolic byproduct of doxorubicin interacting with cancer cells, was causing the toxic effect.
To test this, they added doxorubicinol to heart cells and liver cancer cells cultured separately in small wells. It was toxic to the heart cells but not to the cancer cells.
When doxorubicin alone is added to the liver cancer cells, the amount of doxorubicinol produced is too small to be toxic to the heart cells. The team believes this is because the amount of cell culture medium needed for the well-based tests dilutes the metabolite.
In contrast, when doxorubicin is introduced into the iHCC, the metabolite is not diluted when moving through the microchannel circulation system because a smaller volume of cell culture is needed. As a result, the drug does have a toxic effect on the heart cells via its metabolite.
The device requires further improvements, but the study demonstrates how this design concept could be used to investigate the toxic side effects of anti-cancer drugs on heart cells well before expensive clinical trials. The study was published in the journal Royal Society of Chemistry Advances.
Learn more: Next-generation drug testing on chips
The Latest on: Body-on-a-chip
- Google Pixel 6 with the new Tensor Chip & 8G RAM appears on Geekbenchon October 13, 2021 at 1:08 am
Google will officially unveil its all-new series, Google Pixel 6 series. According to reports, this flagship series will arrive on October ...
- Investigation Underway After Body Found On Ensley Roadon October 12, 2021 at 11:19 pm
The Escambia County Sheriff’s Office is investigating the death of a man whose body was found in Brent on Tuesday as a homicide. The body of a black male believed to be in his late 30s or early 40s ...
- ‘Eat it!’: Chip Roy tells to Southwest airlines to shove their nonsense, expect to return bailout fundson October 12, 2021 at 8:39 am
Rep. Chip Roy called for Southwest Airlines to pay back COVID bailout money over the company's employee vaccine mandate.
- Chip shortage and power crunch hit China auto sales in ‘Golden September’on October 12, 2021 at 12:35 am
China’s auto sales slumped 19.6% in September from a year earlier, industry data showed on Tuesday, falling for a fifth consecutive month as a prolonged global shortage of semiconductors and a ...
- China vehicle sales fall 20% in September – industry bodyon October 11, 2021 at 11:34 pm
China's auto sales slumped 19.6% in September from a year earlier, industry data showed on Tuesday, falling for a fifth ...
- When the chips are down!on October 11, 2021 at 11:04 am
The global semiconductor shortage is disrupting many businesses including manufacturing, automotive, communications, industrial electronics, healthcare, data processing and transportation. This ongoin ...
- Automotive Chip Market worth USD 117.76 billion by 2028, registering a CAGR of 12.27% - Report by Market Research Future (MRFR)on October 11, 2021 at 5:49 am
Automotive Chip Market Overview: According to a comprehensive research report by Market Research Future (MRFR), "Automotive ...
- Body found in Durham elementary school parking lot identified as Virginia homicide suspecton October 10, 2021 at 5:19 am
A body found in a car on the property of Eastway Elementary School has been identified by Newport News police as a Virginia homicide suspect.
- Israel, Palestinian militants use bodies as bargaining chipson October 7, 2021 at 11:16 pm
More than a year after his son was killed by Israeli forces under disputed circumstances in the occupied West Bank, Mustafa Erekat is still ...
- Japanese healthcare startup Bisu raises $3.2M seed round to launch its lab-on-a-chip producton October 6, 2021 at 6:00 pm
The adoption of telehealth services has boomed in the pandemic -- with usage up 38-fold since January 2020, according to a report by McKinsey. In one of the latest developments, Bisu -- a ...
via Google News and Bing News